Attendee search 

Somno-Art is an ambulatory monitoring device allowing the scoring of the user's sleep internal structure with results equivalent to those obtained from the complex polysomnography (PSG). Based on the recordings of two basic and easy-to-measure physiological variables, heart rate and body movements, our in-house software produces a full description of the sleep architecture

Around 20% of the overall population suffers from chronic sleep disorders resulting in tens of billion dollars of productivity losses with serious repercussions on the overall health of people (blood pressure, obesity, chronic fatigue...). Somno-Art will allow easier and faster sleep diagnostics compared to traditional sleep monitoring devices.

Research market / Sleep labs market / Medical market

Medical results / Automatic scoring / Ambulatory / Easy-to-use

GLOBAL CARE Initiative is a French consortium of five non-profit Carnot research institutes dedicated to human health.

• CALYM, the Consortium for the acceleration of innovation and its transfer to the field of Lymphoma
• Curie Cancer, a component of Institut Curie focused on cancers
• ICM, the Brain and Spine Institute dedicated to CNS diseases
• Pasteur MI, the infectious diseases division of the Institut Pasteur
• Voir et Entendre, expert in vision and audition diseases and rehabilitation

Our goal is to operate as a one-stop shop to life sciences companies and research and technological organizations that seek effective R&D partnerships. The Carnot Institutes can collaborate at any stage — from basic research to late clinical phases. GLOBAL CARE Initiative combines strong scientific expertise to unique technology platforms to propose an innovation-centered collaboration offer.

CNS Diseases, Vision and Audition Diseases, Cancers, Lymphoma, Infectious Diseases

The institutes have joined to combine their efforts in fostering their international research partnerships with the industry and other RTOs.

The consortium operates as a one-stop-shop for life science companies and research organizations that seek R&D collaboration from basic research to the late clinical phases

Basic research / Preclinical research / Clinical

One stop shop for all of the insitutes / Translational research collaborations (biobanks-clinical data/trials - Epidemiologic data - Animal/cells models) / Access to European market (Patient population/Cormecial market/ European KOLs/clinical centers)/New sourcing for innovation

CYTOSIAL Biomedic is a pre-clinical medical device startup dedicated to applying its patented chitosan-based breakthrough technology and expertise to the development of medical devices for regenerative medicine and tissue engineering.

We incorporate semiconductor, microelectronics, bio-electronic and drug-formulation innovations into a technology platform from which we are already prototyping products that leap forward with unprecedented safety, ease-of-use and efficiency. Our initial in-vitro results demonstrate an ability to improve transdermic drug delivery by 4 to 10x on a large range of molecules.

Targeted medical applications range from prevention of bedsores to controlled pain-relief and wound healing. Combined with advanced photo-dynamic therapy, we develop advanced solutions for dermatology. Our total addressable market is estimated to reach $7 billion by 2018.

Dermatology (psoriasis, atopic demartitis, labial herpes, acne, alopecia, ...) ; Pain relief (chronic pain, BTP, neuropathic and arthritic pain) ; Bedsores (bedsore prevention, bedsore detection , chronic wounds)

Security and Safety / Controlled Drug Delivery / Programmable-Remote bolus / Measure of compliance

Vibration tonometry enables smart tonometers to measure eye pressure without contact,for ophthalmologists, refractive surgeons , otpicians and optometrists and self monitoring at home.

Vibration tonometers measure eye pressure independently of corneal thickness and even in people with thin corneas or after refractive surgery

1 Ophthalmologists/ 2 Refractive Surgeons/ 3 opticians & Optometrists/ 4 people with glaucoma or at risk

1 Fast Repeated measures/ 2 Works on Thin Cornea/3 Measures Corneal elasticity/4 Works after refrtactive surgery

imedipac is a connceted, rec hageable, pillbox for better treatment adhrence

imedipac's main objective is to increase treatment adherence and measure it 

Patients at home/patients in nursing homes

Well designed connected pillbox/reliability/total traceability/very good knowledge of our market in France

CLEVEXEL Pharma invests its teams' know-how to catalyze innovative drug development projects and ensure their attractiveness on the market.

We are an integrated, one-stop-shop solution for the co-development of promising new therapeutic compounds. We partner with inventors to boost the development of their product from proof-of-concept in an animal model to proof-of-concept in human. The project is then outlicensed to a pharmaceutical company for Phase III and Market Access.

Industry sectors

•  it offers an attractive user friendly meal logging experience, avoiding manual search in a database for most of the foods: the scanning user experience takes up to 10 times less clicks to log a food than a manual self declarative input method /

• spectrometry makes possible accurate analysis of homogeneous food and beverage, taking into account specific cooking and additive ingredient

• the food database and its models will respond accurately on any homogeneous food, even on home made dishes and beverages that do not have a nutritional label /

• DietSensor gives a lot of feedback on food quality and quantity while logging food, making possible immediate behavior changes before eating

The initial product designed is a bioartificial Pancreas, named MAILPAN

MAILPAN

Market segment 1: type 1 diabets/ Market segment 2: liver diseases

Advantage 1: functioning autonomy due to its physiologic implantation site/ Advantage 2: Entry and exit ports allowing filling/emptying of cells when needed/ Advantage 3: Big volume, which allows filling with a sufficient number of cells/ Advantage 4: flat surface allowing to maximise surface exchanges and cells survival and function 

Technology allows for a large quantity of active ingredient to be stored in a polymer matrix for a constant and slow targeted release. The active polymer is either embedded onto textile supports or on self adhesive multi layer long lasting patches or in particles in suspension in a solution. Products include pain relief devices (active textiles or patches), slimming devices, active foot care, mosquito control devices,...

We are able to have products lasting much longer because we can insert a large amount of actives in the device and we control the release kinetic. For instance, istead of having a 8 hour pain relief patch, we can obtain a reusable, washable patch equivalent lasting several weeks.

Rheumatology/ Orthopedics / Dermatology / Slimming / Parasite control

Long lasting active release / Constant release / Targeted area